Skip to main content



Page 5 of 95

  1. Content type: Research article

    Estrogen promotes breast cancer development and progression mainly through estrogen receptor (ER). However, blockage of estrogen production or action prevents development of and suppresses progression of ER-ne...

    Authors: Chuying Wang, Feng Bai, Li-han Zhang, Alexandria Scott, Enxiao Li and Xin-Hai Pei

    Citation: Breast Cancer Research 2018 20:74

    Published on:

  2. Content type: Research article

    In over 20% of breast conserving operations, postoperative pathological assessment of the excised tissue reveals positive margins, requiring additional surgery. Current techniques for intra-operative assessmen...

    Authors: Dustin W. Shipp, Emad A. Rakha, Alexey A. Koloydenko, R. Douglas Macmillan, Ian O. Ellis and Ioan Notingher

    Citation: Breast Cancer Research 2018 20:69

    Published on:

    The Editorial to this article has been published in Breast Cancer Research 2018 20:85

  3. Content type: Correction

    After the publication of this work [1], an error was noticed in Fig. 2b, Fig. 3a and Fig. 5b. The Skp1 loading control was accidentally duplicated. We apologize for this error, which did not affect any of the ...

    Authors: Ma’anit Shapira, Eli Kakiashvili, Tzur Rosenberg and Dan D. Hershko

    Citation: Breast Cancer Research 2018 20:68

    Published on:

    The original article was published in Breast Cancer Research 2006 8:R46

  4. Content type: Research article

    Circulating tumor cells (CTCs) are the major players in the metastatic process. A potential mechanism of cell migration and invasion is the formation of microtentacles in tumor cells. These structures are supp...

    Authors: G. Kallergi, D. Aggouraki, N. Zacharopoulou, C. Stournaras, V. Georgoulias and S. S. Martin

    Citation: Breast Cancer Research 2018 20:67

    Published on:

  5. Content type: Research article

    Syndecan-1 (Sdc1), a cell surface heparan sulfate proteoglycan normally expressed primarily by epithelia and plasma cells, is aberrantly induced in stromal fibroblasts of breast carcinomas. Stromal fibroblast-...

    Authors: Colleen Chute, Xinhai Yang, Kristy Meyer, Ning Yang, Keelin O’Neil, Ildiko Kasza, Kevin Eliceiri, Caroline Alexander and Andreas Friedl

    Citation: Breast Cancer Research 2018 20:66

    Published on:

  6. Content type: Research article

    The microenvironment and stress factors like glucocorticoids have a strong influence on breast cancer progression but their role in the first stages of breast cancer and, particularly, in myoepithelial cell re...

    Authors: Arantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, Mireia Alcaraz, Xieng Chen, Mario Mancino, Patricia Fernández-Nogueira, Miquel Prats de Puig, Flavia Guzman, Aleix Noguera-Castells, Anna López-Plana, Estel Enreig, Neus Carbó, Vanessa Almendro, Pedro Gascón, Paloma Bragado…

    Citation: Breast Cancer Research 2018 20:65

    Published on:

  7. Content type: Research article

    Adjuvant radiotherapy is the standard of care after breast-conserving surgery for primary breast cancer, despite a majority of patients being over- or under-treated. In contrast to adjuvant endocrine therapy a...

    Authors: Martin Sjöström, Johan Staaf, Patrik Edén, Fredrik Wärnberg, Jonas Bergh, Per Malmström, Mårten Fernö, Emma Niméus and Irma Fredriksson

    Citation: Breast Cancer Research 2018 20:64

    Published on:

  8. Content type: Correction

    After the publication of this work [1] an error in Fig. 1c was brought to our attention: the Western blots for PRDX6 and β-actin were similar to those shown in lanes 5-6 of Fig. 4g. To verify these findings, w...

    Authors: Xin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, Jiong Wu, Jin-Song Lu, Gen-Hong Di, Wei Jin, Zhou-Luo Ou, Zhen-Zhou Shen and Zhi-Ming Shao

    Citation: Breast Cancer Research 2018 20:63

    Published on:

    The original article was published in Breast Cancer Research 2007 9:R76

  9. Content type: Research article

    Tumor-infiltrating lymphocytes (TILs) evaluated in primary breast cancer (BC) convey prognostic information. Limited data in the metastatic setting are available.

    Authors: Maria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, Federico Piacentini, Guido Ficarra, Gaia Griguolo, Federica Miglietta, Tommaso Giarratano, Claudia Omarini, Serena Bonaguro, Rocco Cappellesso, Camillo Aliberti, Grazia Vernaci, Carlo Alberto Giorgi, Giovanni Faggioni, Giulia Tasca…

    Citation: Breast Cancer Research 2018 20:62

    Published on:

  10. Content type: Correction

    After the publication of this work [1] errors were noticed in the total protein loading controls for Figs. 1C, 2B, 3B and 4B.

    Authors: Kheng Tian Lim, Niamh Cosgrave, Arnold David Hill and Leonie S. Young

    Citation: Breast Cancer Research 2018 20:61

    Published on:

    The original article was published in Breast Cancer Research 2006 8:R33

  11. Content type: Research article

    Endocrine resistance in estrogen receptor-positive (ER+) breast cancer is a major clinical problem and is associated with accelerated cancer cell growth, increased motility and acquisition of mesenchymal chara...

    Authors: Carla L. Alves, Daniel Elias, Maria B. Lyng, Martin Bak and Henrik J. Ditzel

    Citation: Breast Cancer Research 2018 20:60

    Published on:

  12. Content type: Research article

    As crucial regulators of the immune response against pathogens, macrophages have been extensively shown also to be important players in several diseases, including cancer. Specifically, breast cancer macrophag...

    Authors: Sara Donzelli, Elisa Milano, Magdalena Pruszko, Andrea Sacconi, Silvia Masciarelli, Ilaria Iosue, Elisa Melucci, Enzo Gallo, Irene Terrenato, Marcella Mottolese, Maciej Zylicz, Alicja Zylicz, Francesco Fazi, Giovanni Blandino and Giulia Fontemaggi

    Citation: Breast Cancer Research 2018 20:59

    Published on:

  13. Content type: Research article

    Numerous studies have analyzed associations between apparent diffusion coefficient (ADC) and histopathological features such as Ki-67 proliferation index in breast cancer (BC), with mixed results. The purpose ...

    Authors: Alexey Surov, Paola Clauser, Yun-Woo Chang, Lihua Li, Laura Martincich, Savannah C. Partridge, Jin You Kim, Hans Jonas Meyer and Andreas Wienke

    Citation: Breast Cancer Research 2018 20:58

    Published on:

  14. Content type: Correction

    After the publication of this work [1] an error was noticed in Fig. 3a and Fig. 5a.

    Authors: Joan S. Lewis-Wambi, Helen R. Kim, Chris Wambi, Roshani Patel, Jennifer R. Pyle, Andres J. Klein-Szanto and V. Craig Jordan

    Citation: Breast Cancer Research 2018 20:57

    Published on:

    The original article was published in Breast Cancer Research 2008 10:R104

  15. Content type: Research article

    Breast cancer pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) varies with tumor subtype. The purpose of this study was to identify an early treatment window for predicting pCR based on tum...

    Authors: Quing Zhu, Susan Tannenbaum, Scott H. Kurtzman, Patricia DeFusco, Andrew Ricci Jr, Hamed Vavadi, Feifei Zhou, Chen Xu, Alex Merkulov, Poornima Hegde, Mark Kane, Liqun Wang and Kert Sabbath

    Citation: Breast Cancer Research 2018 20:56

    Published on:

  16. Content type: Research article

    Altered lipid metabolism is an emerging hallmark of aggressive breast cancers. The N-myc downstream regulated gene (NDRG1) gene plays a critical role in peripheral nervous system myelination, as inactivating m...

    Authors: Christopher J. Sevinsky, Faiza Khan, Leila Kokabee, Anza Darehshouri, Krishna Rao Maddipati and Douglas S. Conklin

    Citation: Breast Cancer Research 2018 20:55

    Published on:

  17. Content type: Research article

    Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to treat TNBC effectively, but chemotherapy is still the...

    Authors: Kideok Jin, Niranjan B. Pandey and Aleksander S. Popel

    Citation: Breast Cancer Research 2018 20:54

    Published on:

  18. Content type: Research article

    Systemic and chronic inflammatory conditions in patients with breast cancer have been associated with reduced patient survival and increased breast cancer aggressiveness. This paper characterizes the role of a...

    Authors: Ken Tawara, Celeste Bolin, Jordan Koncinsky, Sujatha Kadaba, Hunter Covert, Caleb Sutherland, Laura Bond, Joseph Kronz, Joel R. Garbow and Cheryl L. Jorcyk

    Citation: Breast Cancer Research 2018 20:53

    Published on:

  19. Content type: Research article

    Resected HER2 breast cancer patients treated with adjuvant trastuzumab and chemotherapy have superior survival compared to patients treated with chemotherapy alone. We previously showed that trastuzumab and ch...

    Authors: Nadine Norton, Nicholas Fox, Christie-Ann McCarl, Kathleen S. Tenner, Karla Ballman, Courtney L. Erskine, Brian M. Necela, Donald Northfelt, Winston W. Tan, Carmen Calfa, Mark Pegram, Gerardo Colon-Otero, Edith A. Perez, Raphael Clynes and Keith L. Knutson

    Citation: Breast Cancer Research 2018 20:52

    Published on:

  20. Content type: Research article

    The purpose of this work was to investigate noninvasive early detection of treatment response of breast cancer patients to neoadjuvant chemotherapy (NAC) using chemical exchange saturation transfer (CEST) meas...

    Authors: Erwin Krikken, Vitaliy Khlebnikov, Moritz Zaiss, Rajni A. Jibodh, Paul J. van Diest, Peter R. Luijten, Dennis W. J. Klomp, Hanneke W. M. van Laarhoven and Jannie P. Wijnen

    Citation: Breast Cancer Research 2018 20:51

    Published on:

  21. Content type: Research article

    Obesity and type II diabetes are linked to increased breast cancer risk in postmenopausal women. Patients treated with the antidiabetic drug metformin for diabetes or metabolic syndrome have reduced breast can...

    Authors: Erin D. Giles, Sonali Jindal, Elizabeth A. Wellberg, Troy Schedin, Steven M. Anderson, Ann D. Thor, Dean P. Edwards, Paul S. MacLean and Pepper Schedin

    Citation: Breast Cancer Research 2018 20:50

    Published on:

  22. Content type: Research article

    The percentage of mammographic dense tissue (PD) defined by pixel value threshold is a well-established risk factor for breast cancer. Recently there has been some evidence to suggest that an increased thresho...

    Authors: Chao Wang, Adam R. Brentnall, Jack Cuzick, Elaine F. Harkness, D. Gareth Evans and Susan Astley

    Citation: Breast Cancer Research 2018 20:49

    Published on:

  23. Content type: Research article

    Circulating tumor cells (CTCs) carry independent prognostic information in patients with metastatic breast cancer (MBC) on different lines of therapy. Moreover, CTC clusters are suggested to add prognostic inf...

    Authors: Anna-Maria Larsson, Sara Jansson, Pär-Ola Bendahl, Charlotte Levin Tykjaer Jörgensen, Niklas Loman, Cecilia Graffman, Lotta Lundgren, Kristina Aaltonen and Lisa Rydén

    Citation: Breast Cancer Research 2018 20:48

    Published on:

  24. Content type: Research article

    Endocrine therapies are the mainstay of treatment for oestrogen receptor (ER)-positive (ER+) breast cancer (BC). However, resistance remains problematic largely due to enhanced cross-talk between ER and growth fa...

    Authors: Ricardo Ribas, Sunil Pancholi, Aradhana Rani, Eugene Schuster, Stephanie K. Guest, Joanna Nikitorowicz-Buniak, Nikiana Simigdala, Allan Thornhill, Francesca Avogadri-Connors, Richard E. Cutler Jr, Alshad S. Lalani, Mitch Dowsett, Stephen R. Johnston and Lesley-Ann Martin

    Citation: Breast Cancer Research 2018 20:44

    Published on:

  25. Content type: Correction

    After the publication of this article [1] we noticed that in Fig. 1, the gel images (1A and 1B lower panel) were incorrect.

    Authors: Anastasios D. Papanastasiou, Chaido Sirinian and Haralabos P. Kalofonos

    Citation: Breast Cancer Research 2018 20:47

    Published on:

    The original article was published in Breast Cancer Research 2012 14:R112

  26. Content type: Research article

    Background parenchymal uptake (BPU), which refers to the level of Tc-99m sestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), has been identified as a breast cancer risk fact...

    Authors: Carrie B. Hruska, Jennifer R. Geske, Tiffinee N. Swanson, Alyssa N. Mammel, David S. Lake, Armando Manduca, Amy Lynn Conners, Dana H. Whaley, Christopher G. Scott, Rickey E. Carter, Deborah J. Rhodes, Michael K. O’Connor and Celine M. Vachon

    Citation: Breast Cancer Research 2018 20:46

    Published on:

  27. Content type: Research article

    MicroRNAs (miRNAs) regulate gene expression and influence cancer. Primary transcripts of miRNAs (pri-miRNAs) are poorly annotated and little is known about the role of germline variation in miRNA genes and bre...

    Authors: Jeannette T. Bensen, Mariaelisa Graff, Kristin L. Young, Praveen Sethupathy, Joel Parker, Chad V. Pecot, Kevin Currin, Stephen A. Haddad, Edward A. Ruiz-Narváez, Christopher A. Haiman, Chi-Chen Hong, Lara E. Sucheston-Campbell, Qianqian Zhu, Song Liu, Song Yao, Elisa V. Bandera…

    Citation: Breast Cancer Research 2018 20:45

    Published on:

  28. Content type: Research article

    Proteolytic impairment of the Fc effector functions of therapeutic monoclonal antibodies (mAbs) can compromise their antitumor efficacy in the tumor microenvironment and may represent an unappreciated mechanis...

    Authors: Hao-Ching Hsiao, Xuejun Fan, Robert E. Jordan, Ningyan Zhang and Zhiqiang An

    Citation: Breast Cancer Research 2018 20:43

    Published on:

  29. Content type: Research article

    Psychiatric medications are widely prescribed in the USA. Many antipsychotics cause serum hyperprolactinemia as an adverse side effect; prolactin-Janus kinase 2 (JAK2)-signal transducer and activator of transc...

    Authors: A. N. Johnston, W. Bu, S. Hein, S. Garcia, L. Camacho, L. Xue, L. Qin, C. Nagi, S. G. Hilsenbeck, J. Kapali, K. Podsypanina, J. Nangia and Y. Li

    Citation: Breast Cancer Research 2018 20:42

    Published on:

  30. Content type: Research article

    The RhoA activating protein Net1 contributes to breast cancer cell proliferation, motility, and invasion in vitro, yet little is known about its roles in mammary gland tumorigenesis and metastasis.

    Authors: Yan Zuo, Arzu Ulu, Jeffrey T. Chang and Jeffrey A. Frost

    Citation: Breast Cancer Research 2018 20:41

    Published on:

  31. Content type: Short report

    Detection of circulating ESR1 mutations is associated with acquired resistance to aromatase inhibitor (AI) in metastatic breast cancer. Until now, the presence of circulating ESR1 mutations at the end of adjuvant...

    Authors: Violette Allouchery, Ludivine Beaussire, Anne Perdrix, David Sefrioui, Laetitia Augusto, Cécile Guillemet, Nasrin Sarafan-Vasseur, Frédéric Di Fiore and Florian Clatot

    Citation: Breast Cancer Research 2018 20:40

    Published on:

  32. Content type: Review

    Atypical ductal hyperplasia (ADH) is a common diagnosis in the mammographic era and a significant clinical problem with wide variation in diagnosis and treatment. After a diagnosis of ADH on biopsy a proportio...

    Authors: Tanjina Kader, Prue Hill, Emad A. Rakha, Ian G. Campbell and Kylie L. Gorringe

    Citation: Breast Cancer Research 2018 20:39

    Published on:

  33. Content type: Research article

    Cognitive decline is among the most feared treatment-related outcomes of older adults with cancer. The majority of older patients with breast cancer self-report cognitive problems during and after chemotherapy...

    Authors: Bihong T. Chen, Sean K. Sethi, Taihao Jin, Sunita K. Patel, Ningrong Ye, Can-Lan Sun, Russell C. Rockne, E. Mark Haacke, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan…

    Citation: Breast Cancer Research 2018 20:38

    Published on:

  34. Content type: Research article

    Rapidly evolving understanding of cancer biology has presented novel opportunities to translate that understanding into clinically relevant therapy. Palbociclib, a novel, first-in-class cyclin-dependent kinase...

    Authors: J. K. Kish, M. A. Ward, D. Garofalo, H. V. Ahmed, L. McRoy, J. Laney, G. Zanotti, J. Braverman, H. Yu and B. A. Feinberg

    Citation: Breast Cancer Research 2018 20:37

    Published on:

  35. Content type: Research article

    Texture patterns have been shown to improve breast cancer risk segregation in addition to area-based mammographic density. The additional value of texture pattern scores on top of volumetric mammographic densi...

    Authors: Johanna O. P. Wanders, Carla H. van Gils, Nico Karssemeijer, Katharina Holland, Michiel Kallenberg, Petra H. M. Peeters, Mads Nielsen and Martin Lillholm

    Citation: Breast Cancer Research 2018 20:36

    Published on:

  36. Content type: Research article

    The majority of estrogen receptor-positive (ERα+) breast cancers respond to endocrine therapies. However, resistance to endocrine therapies is common in 30% of cases, which may be due to altered ERα signaling and...

    Authors: Maria B. Padua, Poornima Bhat-Nakshatri, Manjushree Anjanappa, Mayuri S. Prasad, Yangyang Hao, Xi Rao, Sheng Liu, Jun Wan, Yunlong Liu, Kyle McElyea, Max Jacobsen, George Sandusky, Sandra Althouse, Susan Perkins and Harikrishna Nakshatri

    Citation: Breast Cancer Research 2018 20:35

    Published on:

  37. Content type: Research Article

    The main purpose was to investigate the correlation between magnetic resonance imaging (MRI)-based response patterns halfway through neoadjuvant chemotherapy and immunotherapy (NAC) and pathological tumor resp...

    Authors: Briete Goorts, Kelly M. A. Dreuning, Janneke B. Houwers, Loes F. S. Kooreman, Evert-Jan G. Boerma, Ritse M. Mann, Marc B. I. Lobbes and Marjolein L. Smidt

    Citation: Breast Cancer Research 2018 20:34

    Published on:

  38. Content type: Research Article

    Younger age at onset of breast development, which has been declining in recent decades, is associated with increased breast cancer risk independent of age at menarche. Given the need to study the drivers of th...

    Authors: Lauren C. Houghton, Julia A. Knight, Mary Jane De Souza, Mandy Goldberg, Melissa L. White, Karen O’Toole, Wendy K. Chung, Angela R. Bradbury, Mary B. Daly, Irene L. Andrulis, Esther M. John, Saundra S. Buys and Mary Beth Terry

    Citation: Breast Cancer Research 2018 20:33

    Published on:

  39. Content type: Research article

    Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNA...

    Authors: Yanchun Zhou, Xiuhua Meng, Shaoying Chen, Wei Li, Delin Li, Robert Singer and Wei Gu

    Citation: Breast Cancer Research 2018 20:32

    Published on:

  40. Content type: Research article

    Breast cancer prognosis is strongly associated with tumor size at diagnosis. We aimed to identify factors associated with diagnosis of large (> 2 cm) compared to small tumors, and to examine implications for l...

    Authors: Fredrik Strand, Keith Humphreys, Johanna Holm, Mikael Eriksson, Sven Törnberg, Per Hall, Edward Azavedo and Kamila Czene

    Citation: Breast Cancer Research 2018 20:31

    Published on:

  41. Content type: Research article

    Leukocyte telomere length (LTL) and mitochondrial genome (mtDNA) copy number and deletions have been proposed as risk markers for various cancer types, including breast cancer (BC).

    Authors: Daniele Campa, Myrto Barrdahl, Aurelia Santoro, Gianluca Severi, Laura Baglietto, Hanane Omichessan, Rosario Tumino, H. B(as). Bueno-de-Mesquita, Petra H. Peeters, Elisabete Weiderpass, Maria-Dolores Chirlaque, Miguel Rodríguez-Barranco, Antonio Agudo, Marc Gunter, Laure Dossus, Vittorio Krogh…

    Citation: Breast Cancer Research 2018 20:29

    Published on:

  42. Content type: Research Article

    The ataxia telangiectasia mutated (ATM) gene is a moderate-risk breast cancer susceptibility gene; germline loss-of-function variants are found in up to 3% of hereditary breast and ovarian cancer (HBOC) families ...

    Authors: Anne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, Guillaume Bataillon, Eve Cavaciuti, Dorothée Le Gal, Elodie Girard, Tatiana Popova, Philippe La Rosa, Juana Beauvallet, Séverine Eon-Marchais, Marie-Gabrielle Dondon, Catherine Dubois d’Enghien, Anthony Laugé, Walid Chemlali, Virginie Raynal…

    Citation: Breast Cancer Research 2018 20:28

    Published on:

  43. Content type: Research Article

    Patients with breast cancer who have a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) have improved survival. We hypothesize that once pCR has been achieved, there is no difference in subse...

    Authors: Anna Weiss, Sami I. Bashour, Kenneth Hess, Alastair M. Thompson and Nuhad K. Ibrahim

    Citation: Breast Cancer Research 2018 20:27

    Published on:

  44. Content type: Research article

    The recommendation for chemotherapy in early-stage breast cancer patients has been refined by the 21-gene Recurrence Score. However, uncertainty remains whether patients in the Intermediate Risk category benef...

    Authors: Jonathan Chen, Xian Wu, Paul J. Christos, Silvia Formenti and Himanshu Nagar

    Citation: Breast Cancer Research 2018 20:26

    Published on:

  45. Content type: Research Article

    The isocitrate dehydrogenase (IDH) gene family expresses key functional metabolic enzymes in the Krebs cycle and mediates the epigenetic reprogramming, which serves as an important biomarker of breast cancer. ...

    Authors: Wen-Shan Liu, Shih-Hsuan Chan, Hong-Tai Chang, Guan-Cheng Li, Ya-Ting Tu, Hui-Hwa Tseng, Ting-Ying Fu, Hui-Yu Chang, Huei-Han Liou, Luo-Ping Ger and Kuo-Wang Tsai

    Citation: Breast Cancer Research 2018 20:25

    Published on:

  46. Content type: Research article

    The interaction of breast cancer cells with other cells in the tumor microenvironment plays an important role in metastasis. Invasion and intravasation, two critical steps in the metastatic process, are influe...

    Authors: Ramon M. Cabrera, Serena P. H. Mao, Chinmay R. Surve, John S. Condeelis and Jeffrey E. Segall

    Citation: Breast Cancer Research 2018 20:24

    Published on:

  47. Content type: Research Article

    Phosphatase and tensin homolog (PTEN) is one of the most frequently inactivated tumor suppressors in breast cancer. While PTEN itself is not considered a druggable target, PTEN synthetic-sick or synthetic-leth...

    Authors: Yew Chung Tang, Szu-Chi Ho, Elisabeth Tan, Alvin Wei Tian Ng, John R. McPherson, Germaine Yen Lin Goh, Bin Tean Teh, Frederic Bard and Steven G. Rozen

    Citation: Breast Cancer Research 2018 20:22

    Published on:

  48. Content type: Research Article

    Breast cancer (BC) is a heterogeneous disease characterised by variant biology and patient outcome. The amino acid transporter, SLC7A5, plays a role in BC although its impact on patient outcome in different BC...

    Authors: Rokaya El Ansari, Madeleine L. Craze, Islam Miligy, Maria Diez-Rodriguez, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha and Andrew R. Green

    Citation: Breast Cancer Research 2018 20:21

    Published on:

  49. Content type: Research Article

    Early-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored novel serum proteins as surrog...

    Authors: Bashar Zeidan, Antigoni Manousopoulou, Diana J. Garay-Baquero, Cory H. White, Samantha E. T. Larkin, Kathleen N. Potter, Theodoros I. Roumeliotis, Evangelia K. Papachristou, Ellen Copson, Ramsey I. Cutress, Stephen A. Beers, Diana Eccles, Paul A. Townsend and Spiros D. Garbis

    Citation: Breast Cancer Research 2018 20:19

    Published on:

Annual Journal Metrics